Gene therapy for TTP is still an emerging area of research, but it holds potential in patients with cTTP, where a functional copy of the ADAMTS13 gene would likely restore enzyme function. The gene discussed is ADAMTS13; the disease is thrombotic thrombocytopenic purpura.